- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Investors bow to Sensei series A
Cambrian Biopharma co-led a $28.5m round for cancer immunotherapy developer Sensei Biotherapeutics with venture capital firm H&S Ventures.
Oct 10, 2020Doherty and Delph take Magic Leap roles
John Doherty, a GCV Powerlist award winner, becomes CFO as Walter Delph heads business.
Oct 10, 2020Corporate venturing deal net: 5-9 October 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Oct 9, 2020Daily deal net: October 9, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Oct 9, 2020UPMC crosses Abridge for $15m
Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.
Oct 9, 2020Gamma Biosciences absorbs Nanopareil
Nanopareil employs nanofibre membranes to separate chemical compounds for the purposes of purifying biopharmaceutical candidates.
Oct 9, 2020Big Hit braces for $842m IPO
Big Hit Entertainment, the Netmarble-backed talent management agency and record company, priced its initial public offering at the top of its range.
Oct 9, 2020Will Ventures locks down $50m fund
University endowment-backed Will Ventures aims to unlock sports-related innovation across markets such as fitness, media and gaming.
Oct 9, 2020A2 coordinates $71.5m series B
UC Investments has backed cancer cell therapy developer A2 Biotherapeutics, bringing the company's total funding to $136m.
Oct 9, 2020GoPuff gets $380m in SoftBank-backed round
Returning investor SoftBank Vision Fund came back for a round that valued the consumer product delivery platform at $3.9bn.
Oct 9, 2020Instacart picks up another $200m
The Comcast, American Express and Amazon-backed grocery delivery service increased its valuation to $17.7bn in a round co-led by Valiant Peregrine Fund and D1 Capital Partners.
Oct 9, 2020A2 coordinates series B round
Oncology therapy developer A2 Biotherapeutics raised $71.5m from investors including Hartford HealthCare Endowment to take its funding to $136m altogether.
Oct 9, 2020Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


